American Portfolios Advisors’s Royalty Pharma RPRX Stock Holding History

American Portfolios Advisors’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$442	Hold	11	–	–	﹤0.01%	3398
2022 Q2	$462	Hold	11	–	–	﹤0.01%	3401
2022 Q1	$429	Hold	11	–	–	﹤0.01%	3483
2021 Q4	$438	Hold	11	–	–	﹤0.01%	3423
2021 Q3	$398	Hold	11	–	–	﹤0.01%	3399
2021 Q2	$451	Hold	11	–	–	﹤0.01%	3330
2021 Q1	$480	Hold	11	–	–	﹤0.01%	3209
2020 Q4	$551	Sell	11 -25	-69%	-$1.06K	﹤0.01%	2898
2020 Q3	$1.51K	Sell	36 -57,375	-100%	-$2.46M	﹤0.01%	2686
2020 Q2	$2.79M	Buy	+57,411	New	+$2.84M	0.18%	118

Other funds holding RPRX

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SGA

Siguler Guff Advisers New York $56.1M AUM 46.63% 1-Year Est. Return

American Portfolios Advisors's RPRX Position: Q3 2022 in Review

American Portfolios Advisors held its Royalty Pharma (RPRX) position steady in Q3 2022 at 11 shares worth $442. The position accounts for ﹤0.01% of the portfolio, ranked #3398.

American Portfolios Advisors first reported a position in RPRX in Q2 2020 and has held it in 10 quarters since. The position peaked at $2.79M in Q2 2020. 319 funds tracked by Wall St. Rank hold RPRX as of Q3 2022.

American Portfolios Advisors held 11 shares of Royalty Pharma worth $442 as of Q3 2022.
American Portfolios Advisors left its Royalty Pharma share count unchanged in Q3 2022.
Royalty Pharma made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #3398 holding.
American Portfolios Advisors first reported a position in Royalty Pharma in Q2 2020 and has held it in 10 quarters since.
American Portfolios Advisors's Royalty Pharma position peaked at $2.79M in Q2 2020.
319 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.